Dasatinib
About
Therapy type: Targeted therapy
Therapy strategy: BCR-ABL inhibition
Mappings
NCI Thesaurus: Dasatinib (coding:ncit:C38713)
RxNorm: dasatinib (coding:rxcui:475342, coding:omop:1358436)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| EMA (3) FDA (6) | BCR::ABL1 | Chronic Myeloid Leukemia, BCR-ABL1+ | Dasatinib | |
| FDA (4) | BCR::ABL1 | Acute Lymphoblastic Leukemia | Dasatinib | |
| EMA (2) | not BCR::ABL1 | Acute Lymphoblastic Leukemia | Dasatinib |